UK markets closed

Provectus Biopharmaceuticals, Inc. (PVCT)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
0.1585+0.0095 (+6.38%)
At close: 11:10AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
76.576
21.605
682.984
97.231
-
Total cash
76.576
21.605
682.984
97.231
-
Net receivables
0.476
0.394
5.107
3.93
-
Other current assets
337.522
467.081
329.908
322.518
-
Total current assets
1,365
1,899
3,442
423.679
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
195.04
240.137
162.577
243.835
-
Accumulated depreciation
-110.994
-102.073
-91.178
-78.313
-
Net property, plant and equipment
84.046
138.064
71.399
165.522
-
Intangible assets
-
-
-
-
228.107
Total non-current assets
84.046
138.064
71.399
165.522
-
Total assets
1,449
2,037
3,513
589.201
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
2,953
2,067
1,698
23,628
-
Accounts payable
1,676
2,094
1,287
956.86
-
Accrued liabilities
963.29
461.182
2,019
6,042
-
Deferred revenues
953.248
1,511
2,500
0
-
Other current liabilities
-
-
150
-
0.001
Total current liabilities
9,017
8,192
7,701
30,712
-
Non-current liabilities
Long-term debt
-
-
-
39.061
19,667
Total non-current liabilities
25.299
73.376
0
83.844
-
Total liabilities
9,042
8,266
7,701
30,796
-
Stockholders' equity
Common stock
442.256
441.617
441.039
398.808
-
Retained earnings
-252,690
-249,589
-246,034
-240,494
-
Accumulated other comprehensive income
-60.165
-35.679
-34.467
-34.097
-
Total stockholders' equity
-7,593
-6,229
-4,187
-30,206
-
Total liabilities and stockholders' equity
1,449
2,037
3,513
589.201
-